Quotes 5-day view Delayed Nasdaq
03/01/2021
03/02/2021
03/03/2021
03/04/2021
03/05/2021
Date
47.85(c)
47.44(c)
47.63(c)
46.86(c)
47.2(c)
Last
5 489 988
4 142 801
4 568 751
5 252 552
6 145 464
Volume
-0.17% -0.86% +0.40% -1.62% +0.73% Change
Sales 2021
143 B - -
Net income 2021
2 597 M - -
Net Debt 2021
12 004 M - -
P/E ratio 2021
14,0x
Yield 2021
4,04%
Sales 2022
148 B - -
Net income 2022
3 529 M - -
Net Debt 2022
11 003 M - -
P/E ratio 2022
11,7x
Yield 2022
4,16%
Capitalization
40 783 M 40 783 M -
EV / Sales 2021
0,37x
EV / Sales 2022
0,35x
Nbr of Employees
277 000
Free-Float
61,0%
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:
- retail distribution (83.1%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2020, the activity is ensured through 13,449 outlets (including 9,021 in the United...
Notations Surperformance© of Walgreens Boots Alliance, Inc.
Trading Rating : Investor Rating :
All news about WALGREENS BOOTS ALLIANCE, INC.
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
One of the few top U.S. Black CEOs, Merck's Ken Frazier to retire
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
22
Average target price
47,58 $
Last Close Price
47,20 $
Spread / Highest target
35,6%
Spread / Average Target
0,80%
Spread / Lowest Target
-21,6%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
